However, when investigating patients who are obese with relatively normal ALT and AST with abnormal FIB4 score, there an increased chance for these patients to have an abnormal value on the NAFLD score. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.